The Korean journal of internal medicine

  • 제22권2호
  • /
  • Pages.73-76
  • /
  • 2007
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Clinical Outcomes of Delayed Clearance of Serum HBsAg in Patients with Chronic HBV Infection

  • Nam, Soon-Woo (Department of Internal Medicine, The Catholic University of Korea College of Medicine, WHO Collaborating Center for Reference and Research on Viral Hospital) ;
  • Jung, Jeong-Jo (Department of Internal Medicine, The Catholic University of Korea College of Medicine, WHO Collaborating Center for Reference and Research on Viral Hospital) ;
  • Bae, Si-Hyun (Department of Internal Medicine, The Catholic University of Korea College of Medicine, WHO Collaborating Center for Reference and Research on Viral Hospital) ;
  • Choi, Jong-Young (Department of Internal Medicine, The Catholic University of Korea College of Medicine, WHO Collaborating Center for Reference and Research on Viral Hospital) ;
  • Yoon, Seung-Kew (Department of Internal Medicine, The Catholic University of Korea College of Medicine, WHO Collaborating Center for Reference and Research on Viral Hospital) ;
  • Cho, Se-Hyun (Department of Internal Medicine, The Catholic University of Korea College of Medicine, WHO Collaborating Center for Reference and Research on Viral Hospital) ;
  • Han, Joon-Yeol (Department of Internal Medicine, The Catholic University of Korea College of Medicine, WHO Collaborating Center for Reference and Research on Viral Hospital) ;
  • Han, Nam-Ik (Department of Internal Medicine, The Catholic University of Korea College of Medicine, WHO Collaborating Center for Reference and Research on Viral Hospital) ;
  • Yang, Jin-Mo (Department of Internal Medicine, The Catholic University of Korea College of Medicine, WHO Collaborating Center for Reference and Research on Viral Hospital) ;
  • Lee, Young-Suk (Department of Internal Medicine, The Catholic University of Korea College of Medicine, WHO Collaborating Center for Reference and Research on Viral Hospital)
  • 발행 : 20070600
⟨ 이전 논문 다음 논문 ⟩

초록

Background : Spontaneous delayed clearance of hepatitis B surface antigen (HBsAg) in patients with chronic HBV infection is a rare event. The aim of this study was to investigate the incidence of delayed clearance of serum HBsAg in chronic HBV infection and to determine the characteristics and clinical outcomes of HBsAg delayed clearance in Korean patients. Methods : From April 1981 to June 2003, 4,061 patients who were positive for HBsAg were evaluated retrospectively. The following assessments were undertaken in 47 patients who had spontaneous delayed clearance: liver biochemistry, viral markers, α-fetoprotein levels, and radiographic examinations including ultrasonography every three to six months for 6-264 months (median 87.9 months). Results : Twenty-four of 47 patients were asymptomatic carriers. The others included seven patients with chronic hepatitis, seven with liver cirrhosis and nine with hepatocellular carcinoma. The estimated annual incidence of HBsAg seroclearance was 0.4%. The time span from positive HBsAg to HBsAg seroclearance in the AHC, CH, LC, and HCC was 62.9, 141, 63, and 95.3 months during follow up. Twenty-four of 24 AHC remained normal, 5 of 7 CH remained as CH and 2 patients remained normal, 1 of 7 with LC developed HCC and 6 of the LC remained as LC, and 4 of 9 HCC patients died. Conclusion : The clinical course following delayed clearance of HBsAg had diverse outcomes from AHC to HCC. Therefore, these patients require close follow up for the possible development of hepatocellular carcinoma following HBsAg clearance.

키워드

과제정보

This article was financially supported by grants from the Medical College of the Catholic University of Korea.

참고문헌

  1. Liaw YF. Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 8:493-496, 1988 https://doi.org/10.1002/hep.1840080310
  2. Liaw YF. Natural history of chronic hepatitis B virus infection. In: Liaw YF, ed. Chronic hepatitis. p. 9-18, Amsterdam, Elsevier, 1986
  3. de Frachis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, Rumi MG, Donato MF, Ronchi G. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118:191-194, 1993 https://doi.org/10.7326/0003-4819-118-3-199302010-00006
  4. Viola LA, Barrison IG, Coleman JC, Paradinas FJ, Fluker JL, Evans BA, Murray-Lyon IM. Natural history of liver disease in chronic hepatitis B surface antigen carriers. Lancet 2:1156-1159, 1981
  5. Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, Chen CJ, Liaw YF. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 145:1039-1047, 1997 https://doi.org/10.1093/oxfordjournals.aje.a009060
  6. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan. Lancet 2:1129-1133, 1981
  7. Kato Y, Nakao K, Hamasaki K, Kato H, Nakata K, Kusumoto Y, Eguchi K. Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands, Japan. J Gastroenterol 35:201-205, 2000 https://doi.org/10.1007/s005350050331
  8. Chen YC, Sheen IS, Chu CM, Liaw YF. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 123:1084-1089, 2002 https://doi.org/10.1053/gast.2002.36026
  9. Lindsay KL, Redeker AG, Ashcavai M. Delayed HBsAg clearance in chronic hepatitis B viral infection. Hepatology 1:586-589, 1981 https://doi.org/10.1002/hep.1840010605
  10. Wu TT, Hsu HC, Chen DS, Sheu JC, Su IJ, Chen SL, Chuang SM. Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma. J Hepatol 4:45-51, 1987 https://doi.org/10.1016/S0168-8278(87)80008-9
  11. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 13:627-631, 1991 https://doi.org/10.1002/hep.1840130403
  12. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 262:369-370, 1993 https://doi.org/10.1126/science.8211155
  13. Fattovich G, Giustina G, Sanchez-Tapias J, Quero C, Mas A, Olivotto PG, Solinas A, Almasio P, Hadziyannis S, Degos F, de Moura MC, Krogsgaard K, Pantalena M, Realdi G, Corrocher R, Schalm SW. Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. Am J Gastroenterol 93:896-900, 1998 https://doi.org/10.1111/j.1572-0241.1998.00272.x
  14. Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 28:231-236, 1998 https://doi.org/10.1002/hep.510280130
  15. Kocak N, Ozen H, Yuce A, Gurakan F. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels. Turk J Pediatr 40:365-372, 1998
  16. Da Silva LC, Madruga CL, Carrilho FJ, Pinho JR, Saez-Alquezar A, Santos C, Bassit L, Barreto C, Fonseca LE, Alves VA, Leitao R, Vianna R, Cardoso RA, Franca AV, Gayotto LC. Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis: lack of correlation with hepatitis C and D virus superinfection. J Gastroenterol 31:696-701, 1996 https://doi.org/10.1007/BF02347619
  17. Sheen IS, Liaw YF, Lin DY, Chu CM. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 170:358-361, 1994 https://doi.org/10.1093/infdis/170.2.358
  18. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 22:1101-1108, 1995
  19. Yeh CT, Chang MH, Lai HY, Chang ML, Chu CM, Liaw YF. Identification of a novel pre-S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen. J Gastroenterol Hepatol 18:1129-1138, 2003 https://doi.org/10.1046/j.1440-1746.2003.03146.x
  20. Liaw YF, Tsai SL, Chang JJ, Sheen IS, Chien RN, Lin DY, Chu CM. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 106:1048- 1053, 1994 https://doi.org/10.1016/0016-5085(94)90766-8
  21. Alberti A, Pontisso P, Chemello L, Fattovich G, Benvegnu L, Belussi F, De Mitri MS. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol 22(Suppl 1):38-41, 1995
  22. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 14:98-102, 1994 https://doi.org/10.1111/j.1600-0676.1994.tb00055.x
  23. Sampliner RE, Hamilton FA, Iseri OA, Tabor E, Boitnott J. The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci 277:17-22, 1979 https://doi.org/10.1097/00000441-197901000-00002
  24. Alward WL, McMahon BJ, Hall DB, Heyward WL. Franchis DP, Bender TR. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis 151:604-609, 1985 https://doi.org/10.1093/infdis/151.4.604